ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
June 22, 2022 09:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces plans to conduct additional internal quality control testing for their new Vitastem products....
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
March 31, 2022 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
October 04, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) is pleased to announce they are launching two new and improved formulas for its top selling product,...
Innosphere Ventures Fund leads investment into bioscience company, GelSana Therapeutics
September 21, 2021 10:41 ET
|
Innosphere Ventures
Golden, CO and Fort Collins, CO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage...
Vascular Ulcers Treatment Market to Surpass US$ 5.08 Billion by end of 2028, Says Coherent Market Insights (CMI)
September 20, 2021 09:05 ET
|
CMI
SEATTLE, Sept. 20, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global vascular ulcers treatment market is estimated to be valued at US$ 3.36 billion in 2021 and is expected...
ViaDerma, Inc. Files Amended Financial Statements
August 24, 2021 10:23 ET
|
ViaDerma, Inc.
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website...
ViaDerma, Inc. Provides Updates on Current Business Activities
June 24, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update on current business activities. The Company has finalized a ten-year $12...
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
June 02, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have expanded their current licensing agreement with a home health wound care...
ViaDerma, Inc. Nearing Initial Order from Large Hospital Network
May 13, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an...
ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record Breaking 1st Quarter
April 08, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, April 08, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update of estimated sales and revenue numbers for the first quarter of 2021, as...